First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient. Issue 1 (8th December 2020) - Fordham, Nicholas; Baker, Emma; Forton, Daniel; Klammer, Matthias; Patel, Kamal; Qadir, Dara; Reyal, Yasmin; Willis, Fenella; Koh, Mickey B.C.